Renovo Neural Inc., is a specialized research organization catering to the needs of the neuroscience community. RNI is at the forefront addressing the next frontier in multiple sclerosis (MS) treatment: Remyelination. The company's pioneering remyelination assays cut months and years from drug development by offering a pre-clinical package to develop therapeutics for debilitating diseases like MS. Furthermore, RNI has advanced 3D-electron microscopy infrastructure to understand cellular and tissue ultrastructure.
Let us help you save months and years of MS drug development time and jumpstart your research programs.
3D-Electron Microscopy |
In Vitro Assays |
In Vivo Assays |